Novartis updates US label on GilenyaR following discussions with the FDA - Reuters

Redirect Notice

 The previous page is sending you to

http://www.reuters.com/article/2012/04/20/idUS121021%2020-Apr-2012%20HUG20120420

.

 If you do not want to visit that page, you can return to the previous page.